source
- Novartis climbs on upbeat drug sales as key readouts loomA return to quarterly sales growth boosted shares higher on Tuesday, though a handful of coming study results will have a bigger impact on the company’s long-term outlook.BioPharma Dive · 10d ago↗ source
- Agios axes next-gen sickle cell candidate after it fails to best Novo’s assetAgios Pharmaceuticals’ sickle cell disease candidate didn’t prove any better than Novo Nordisk’s investigational PK activator or the biopharma’s own asset that is currently under FDA review for the…BioSpace · 10d ago↗ source
- STAT+: Advocates say federal funding is being cut from groups fighting HIVThe administration is shifting some funding to states, but community groups are set to lose out.STAT